|
Market Closed -
Bombay S.E.
06:02:21 2026-08-28 EDT
|
5-day change | 1st Jan Change | ||
| 0.8400 INR | 0.00% |
|
+1.20% | +37.70% |
Company Valuation: Amerise Biosciences Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 54.18 | 109 | 89.85 | 46.25 | 43.61 | 60.12 |
| Change | - | 101.22% | -17.58% | -48.53% | -5.71% | 37.88% |
| Enterprise Value (EV) 1 | 53.93 | 108.8 | 90.55 | 47.01 | 43.39 | 59.9 |
| Change | - | 101.8% | -16.79% | -48.08% | -7.7% | 38.04% |
| P/E | -36.3x | -32.3x | 16.4x | -41.3x | -29.8x | 1,056x |
| PBR | 1x | 2.14x | 1.59x | 0.84x | 0.81x | 1.12x |
| PEG | - | -0x | -0x | 0x | -1x | -10x |
| Capitalization / Revenue | 9,465x | -64.5x | 0.94x | 526x | 121x | 32x |
| EV / Revenue | 9,421x | -64.4x | 0.95x | 534x | 121x | 31.9x |
| EV / EBITDA | - | - | - | - | - | - |
| EV / EBIT | -36.4x | -32.3x | 16.5x | -28.4x | -29.8x | 768x |
| EV / FCF | 1.09x | -40.6x | -62.7x | -40.2x | -38x | 1.95x |
| FCF Yield | 91.8% | -2.46% | -1.6% | -2.49% | -2.63% | 51.3% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -0.0226 | -0.051 | 0.0831 | -0.0169 | -0.0221 | 0.000862 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 0.005724 | -1.69 | 95.77 | 0.088 | 0.359 | 1.88 |
| EBITDA | - | - | - | - | - | - |
| EBIT 1 | -1.483 | -3.371 | 5.492 | -1.658 | -1.457 | 0.078 |
| Net income 1 | -1.491 | -3.371 | 5.492 | -1.189 | -1.461 | 0.057 |
| Net Debt 1 | -0.2513 | -0.1931 | 0.697 | 0.764 | -0.211 | -0.222 |
| Reference price 2 | 0.8200 | 1.6500 | 1.3600 | 0.7000 | 0.6600 | 0.9100 |
| Nbr of stocks (in thousands) | 66,069 | 66,069 | 66,069 | 66,069 | 66,069 | 66,069 |
| Announcement Date | 8/24/20 | 8/26/21 | 8/29/22 | 9/4/23 | 9/5/24 | 8/25/25 |
1INR in Million2INR
Estimates
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- 531681 Stock
- Valuation Amerise Biosciences Limited
Select your edition
All financial news and data tailored to specific country editions
















